OvaScience, Inc. ( OVAS ) saw a big move last session, as the company's shares fell about 8% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for OVAS, as the stock is now down over 12% since Jan 13.ACTELION LTD (ALIOF): Get Free ReportLIGAND PHARMA-B (LGND): Free Stock Analysis ReportOVASCIENCE (OVAS): Free Stock Analysis ReportSUNESIS PHARMA (SNSS): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment Research
The life sciences company has seen 1 downward revision over the past few weeks when it comes to current year estimates, but the consensus for earnings hasn't been in a trend. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
OVAS currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the same sector include Actelion Ltd. ( ALIOF ), Sunesis Pharmaceuticals, Inc. ( SNSS ) and Ligand Pharmaceuticals Incorporated ( LGND ). While Actelion carries a Zacks Rank #1 (Strong Buy), Sunesis Pharmaceuticals and and Ligand Pharmaceuticals hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>